Pathogenesis of Non-Hodgkin's Lymphoma, Journal of Clinical Oncology, vol.29, issue.14, pp.1803-1811, 2011. ,
DOI : 10.1200/JCO.2010.33.3252
The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma, Leukemia, vol.24, issue.10, pp.1781-1784, 2010. ,
DOI : 10.1073/pnas.1137463100
Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy, Journal of Hematology & Oncology, vol.6, issue.1, p.55, 2013. ,
DOI : 10.1158/0008-5472.CAN-08-4898
The phosphatidylinositol 3-Kinase???AKT pathway in human cancer, Nature Reviews Cancer, vol.2, issue.7, pp.489-501, 2002. ,
DOI : 10.1038/nrc839
PI3K/PTEN signaling in tumorigenesis and angiogenesis, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1784, issue.1, pp.19-65, 2009. ,
DOI : 10.1016/j.bbapap.2007.09.008
Signaling by Distinct Classes of Phosphoinositide 3-Kinases, Experimental Cell Research, vol.253, issue.1, pp.239-254, 1999. ,
DOI : 10.1006/excr.1999.4701
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism, Nature Reviews Genetics, vol.61, issue.8, pp.606-619, 2006. ,
DOI : 10.1073/pnas.84.14.5034
The Phosphoinositide 3-Kinase Pathway, Science, vol.296, issue.5573, pp.1655-1657, 2002. ,
DOI : 10.1126/science.296.5573.1655
PI3K-Akt pathway: Its functions and alterations in human cancer, Apoptosis, vol.9, issue.6, pp.667-676, 2004. ,
DOI : 10.1023/B:APPT.0000045801.15585.dd
High Frequency of Mutations of the PIK3CA Gene in Human Cancers, Science, vol.304, issue.5670, p.304554, 2004. ,
DOI : 10.1126/science.1096502
Mutation of the PIK3CA Gene in Ovarian and Breast Cancer, Cancer Research, vol.64, issue.21, pp.7678-7681, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-2933
Frequent monoallelic deletion ofPTEN and its reciprocal associatioin withPIK3CA amplification in gastric carcinoma, International Journal of Cancer, vol.276, issue.3, pp.318-327, 2003. ,
DOI : 10.1002/ijc.10962
Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma, International Journal of Cancer, vol.6, issue.2, pp.242-248, 2005. ,
DOI : 10.1002/ijc.20711
PIK3CA as an oncogene in cervical cancer, Oncogene, vol.19, issue.23, pp.2739-2744, 2000. ,
DOI : 10.1038/sj.onc.1203597
Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity, JNCI Journal of the National Cancer Institute, vol.91, issue.22, pp.911922-1932, 1999. ,
DOI : 10.1093/jnci/91.22.1922
PTEN and the PI3-Kinase Pathway in Cancer, Annual Review of Pathology: Mechanisms of Disease, vol.4, issue.1, pp.127-150, 2009. ,
DOI : 10.1146/annurev.pathol.4.110807.092311
Molecular alterations of theAKT2 oncogene in ovarian and breast carcinomas, International Journal of Cancer, vol.54, issue.4, pp.280-285, 1995. ,
DOI : 10.1002/ijc.2910640412
Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable, Leukemia, vol.17, issue.5, pp.995-997, 2003. ,
DOI : 10.1038/sj.leu.2402874
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer, Nature, vol.1, issue.7152, pp.448439-444, 2007. ,
DOI : 10.1038/nature05933
Expression of a mutated form of the p85?? regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin???s lymphoma-derived cell line (CO), Leukemia, vol.16, issue.5, pp.894-901, 2002. ,
DOI : 10.1038/sj.leu.2402484
The phosphatidylinositol 3?-kinase p85? gene is an oncogene in human ovarian and colon tumors, Cancer Res, issue.20, pp.617426-7429, 2001. ,
Oncogenic Mutations of PIK3CA in Human Cancers, Cell Cycle, vol.3, issue.10, pp.1221-1224, 2004. ,
DOI : 10.4161/cc.3.10.1164
Oncogenic PI3K and its role in cancer, Current Opinion in Oncology, vol.18, issue.1, pp.77-82, 2006. ,
DOI : 10.1097/01.cco.0000198021.99347.b9
PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma, Leukemia, vol.64, issue.11, pp.2368-2370, 2007. ,
DOI : 10.1038/sj.leu.2404873
Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival, Blood, vol.108, issue.13, pp.4178-4186, 2006. ,
DOI : 10.1182/blood-2006-04-016907
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma, Blood, vol.108, issue.5, pp.1668-1676, 2006. ,
DOI : 10.1182/blood-2006-04-015586
Phosphatidylinositol 3'-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma, Clin Cancer Res, issue.18, pp.155724-5732, 2009. ,
Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray, Laboratory Investigation, vol.84, issue.2, pp.235-244, 2004. ,
DOI : 10.1038/labinvest.3700051
Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma, Clinical Cancer Research, vol.11, issue.16, pp.115847-5855, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-0637
CAL-101, a p110?? selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability, Blood, vol.117, issue.2, pp.591-594, 2011. ,
DOI : 10.1182/blood-2010-03-275305
Clinical safety and activity in a phase 1 study of CAL-101, an isoform-selective inhibitor of Phosphatidylinositol 3-Kinase P110 ?, in patients with relapsed or refractory Non-Hodgkin lymphoma, p.1161777, 2010. ,
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies, Expert Opinion on Investigational Drugs, vol.116, issue.21, pp.15-22 ,
DOI : 10.1056/NEJMoa1002965
The 2008 WHO classification of lymphomas: implications for clinical practice and translational research, Hematology, vol.2009, issue.1, pp.523-531, 2009. ,
DOI : 10.1182/asheducation-2009.1.523
Dok-4 Is a Novel Negative Regulator of T Cell Activation, The Journal of Immunology, vol.182, issue.12, pp.1827681-7689, 2009. ,
DOI : 10.4049/jimmunol.0802203
Oncogenic PI3K deregulates transcription and translation, Nature Reviews Cancer, vol.17, issue.12, pp.921-929, 2005. ,
DOI : 10.1038/nrc1753
Genetic Alterations and Aberrant Expression of Genes Related to the Phosphatidyl-lnositol-3???-Kinase/Protein Kinase B (Akt) Signal Transduction Pathway in Glioblastomas, Brain Pathology, vol.84, issue.113 Pt, pp.507-518, 2003. ,
DOI : 10.1111/j.1750-3639.2003.tb00481.x
Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting, Adv Cancer Res, vol.94, pp.29-86, 2005. ,
DOI : 10.1016/S0065-230X(05)94002-5
Constitutive phosphoinositide 3-kinase activation in acute myeloid leukemia is not due to p110?? mutations, Leukemia, vol.103, issue.2, pp.374-376, 2006. ,
DOI : 10.1038/sj.leu.2404054
p110??, a Novel Phosphatidylinositol 3-Kinase Catalytic Subunit That Associates with p85 and Is Expressed Predominantly in Leukocytes, Journal of Biological Chemistry, vol.272, issue.31, pp.110-27219236, 1997. ,
DOI : 10.1074/jbc.272.31.19236
A Crucial Role for the p110?? Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation, The Journal of Experimental Medicine, vol.162, issue.6, pp.753-763, 2002. ,
DOI : 10.1093/emboj/17.2.414
Analysis of Signaling Events by Dynamic Phosphoflow Cytometry, Science Signaling, vol.2, issue.86, p.3, 2009. ,
DOI : 10.1126/scisignal.286pl3
URL : https://hal.archives-ouvertes.fr/inserm-00408711
PHLPP: A Phosphatase that Directly Dephosphorylates Akt, Promotes Apoptosis, and Suppresses Tumor Growth, Molecular Cell, vol.18, issue.1, pp.13-24, 2005. ,
DOI : 10.1016/j.molcel.2005.03.008